Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases | Annals of Hepatology
Fourth COVID-19 booster supercharges antibody defense in older adults, study says
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
JCI - A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
Boosting immunity to Omicron | Nature Medicine
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
Immune imprinting and SARS-CoV-2 vaccine design: Trends in Immunology
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years - The Lancet Regional
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
JKMS :: Journal of Korean Medical Science
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine | BMC Research Notes | Full Text
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 - ScienceDirect
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint | medRxiv
JCI - Durability of immune responses to mRNA booster vaccination against COVID-19
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical ...
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Antibody Response to Omicron BA.4–BA.5 Bivalent Booster | NEJM
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
